CytoDyn, Inc.

CytoDyn, Inc.

CytoDyn, Inc.

Overview
Date Founded

2015

Headquarters

1111 MAIN STREET SUITE 660 VANCOUVER WA 98660

Type of Company

Public

Employees (Worldwide)

19

Industries

Pharmaceuticals
Biotechnology

Company Description

CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, Cancer, graft-versus-host disease (GVHD), and COVID-19. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.

Contact Data
Trying to get in touch with decision makers at CytoDyn, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Director & Head of Quality

Chief Financial & Accounting Officer

Chief Scientific Officer

Chief Technology Officer-Head of Process Sciences, Manufacturing & Supply Chain

Chief Medical Officer, Head of Business Development

Director

Senior Vice President, Global Oncology

Secretary & General Counsel

Board of Directors

Chief Medical Officer, Head of Business Development at CytoDyn, Inc.

Benefit Plan Administrator at University of Portland

President & Chief Executive Officer at CytoDyn, Inc.

Former Medical Director at Centocor, Inc.

Paths to CytoDyn, Inc.
Potential Connections via
Relationship Science
You
CytoDyn, Inc.
Recent Transactions
Details Hidden

CytoDyn, Inc. raised money in a private placement transaction

Details Hidden

CytoDyn, Inc. raised money in a private placement transaction

Details Hidden

CytoDyn, Inc. purchases ProstaGene LLC

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Investment Advisor

Advised onCytoDyn, Inc. raised money in a private placement transaction

Investment Advisor

Advised onCytoDyn, Inc. raised money in a private placement transaction

Advisors & Consultants
Advisor

Founder at Argonne Capital Group LLC

Consultant

Executive Chairman at Biocide, Inc.

Clients

IncellDx, Inc. detects and monitors life threatening diseases. It offers transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. The company was founded by Bruce K. Patterson and Carol Penfold-Patterson on December 3, 2009 and is headquartered in Menlo Park, CA.

Phoenixus AG operates as a research-based pharmaceutical company. It develops and commercializes treatments for diseases and conditions with limited or no treatment options. The firm's products include Daraprim and Vecamyl. The company was founded by Martin Shkreli on February 24, 2015 and is headquartered in Baar, Switzerland.

Key Stats and Financials As of 2020
Market Capitalization
$3B
Total Enterprise Value
$1.25B
Earnings Per Share
$-0.3
Revenue
$0
TEVNet Income
-10.03x
Debt TEV
0.01x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Total Debt
$15.4M
Total Equity
$-2.48M
Net Profit
$-124M
EBITDA
$-72.6M
Suppliers
Samsung BioLogics Co., Ltd. Biotechnology | Inchon, South Korea

SAMSUNG BIOLOGICS Co., Ltd. engages in the provision of contract manufacturing organization services for pharmaceutical products. The company was founded on April 22, 2011 and is headquartered in Incheon, South Korea.

AbbVie, Inc. Hospitals & Patient Services | North Chicago, IL

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on 2013 and is headquartered in North Chicago, IL.

Lonza Group AG Pharmaceuticals | Basel, Che

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CytoDyn, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CytoDyn, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and CytoDyn, Inc..